Rituximab in refractory sarcoidosis: A single centre experience

Clinical and Molecular Allergy

Volumn 13, Issue 1, 2015, Pages

  Cinetto, Francesco ^a   Compagno, Nicolò ^a   Scarpa, Riccardo ^a   Malipiero, Giacomo ^a   Agostini, Carlo ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Granulomatosis; Refractory sarcoidosis; Rituximab

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CALCIUM CHANNEL BLOCKING AGENT; CYCLOPHOSPHAMIDE; DEFLAZACORT; FLUORODEOXYGLUCOSE F 18; HYDROXYCHLOROQUINE; INFLIXIMAB; METHOTREXATE; MYCOPHENOLATE MOFETIL; PREDNISONE; RITUXIMAB; STEROID; TAMOXIFEN;

ADULT; ARTICLE; BREAST CANCER; CASE REPORT; CAUCASIAN; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; COUGHING; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPNEA; ERYTHEMA; EYE FUNDUS; FATIGUE; FEMALE; FEVER; FOLLOW UP; FORCED VITAL CAPACITY; HEPATITIS B; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; HYPERMETABOLISM; HYPERTENSION; INGUINAL PAIN; INTERSTITIAL LUNG DISEASE; LUNG FIBROSIS; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG LAVAGE; LUNG SARCOIDOSIS; LUNG VOLUME; LYMPH NODE BIOPSY; LYMPHADENOPATHY; LYMPHOCYTE; MAINTENANCE THERAPY; MALE; MASTECTOMY; MEDICAL HISTORY; PAROXYSMAL ATRIAL FIBRILLATION; REMISSION; SARCOIDOSIS; SEROLOGY; SKIN DEFECT; THORAX RADIOGRAPHY; THORAX SCINTISCANNING; TREATMENT DURATION; TREATMENT REFUSAL; TREATMENT WITHDRAWAL; VISUAL ACUITY; VISUAL IMPAIRMENT; VITRITIS;

EID: 84940494843     PISSN: None     EISSN: 14767961     Source Type: Journal    
DOI: 10.1186/s12948-015-0025-9     Document Type: Article

References (17)

1. Hunninghake GW, Costabel U, Ando M, Baughman R, Cordier JF, du Bois R et al (1999) ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 16:149-173
2. Crommelin HA, Vorselaars AD, van Moorsel CH, Korenromp IH, Deneer VH, Grutters JC (2014) Anti-TNF therapeutics for the treatment of sarcoidosis. Immunotherapy 6:1127-1143
3. Facco M, Cabrelle A, Teramo A, Olivieri V, Gnoato M, Teolato S et al (2011) Sarcoidosis is a Th1/Th17 multisystem disorder. Thorax 66:144-150
4. Lee NS, Barber L, Akula SM, Sigounas G, Kataria YP, Arce S (2011) Disturbed homeostasis and multiple signaling defects in the peripheral blood B-cell compartment of patients with severe chronic sarcoidosis. Clin Vaccine Immunol 18:1306-1316
5. Geetha D, Hruskova Z, Segelmark M, Hogan J, Morgan MD, Cavero T et al (2015) Rituximab for treatment of severe renal disease in ANCA associated vasculitis. J Nephrol. doi: 10.1007/s40620-015-0208-y
6. Munoz SA, Gandino IJ, Orden AO, Allievi A (2015) Rituximab in the treatment of eosinophilic granulomatosis with polyangiitis. Reumatol Clin 11:165-169
7. Reff ME, Carner K, Chambers KS, Chinn PC, Leonard JE, Raab R et al (1994) Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood 83:435-445
8. Puechal X, Gottenberg JE, Berthelot JM, Gossec L, Meyer O, Morel J et al (2012) Rituximab therapy for systemic vasculitis associated with rheumatoid arthritis: Results from the AutoImmunity and Rituximab Registry. Arthritis Care Res Hoboken 64:331-339
9. Alberici F, Jayne DR (2014) Impact of rituximab trials on the treatment of ANCA-associated vasculitis. Nephrol Dial Transplant 29:1151-1159
10. Alberici F, Smith RM, Jones RB, Roberts DM, Willcocks LC, Chaudhry A et al (2015) Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis. Rheumatology 54(7):1153-1160. doi: 10.1093/rheumatology/keu452
11. Bomprezzi R, Pati S, Chansakul C, Vollmer T (2010) A case of neurosarcoidosis successfully treated with rituximab. Neurology 75:568-570
12. Sawaya R, Radwan W (2013) Sarcoidosis associated with neuromyelitis optica. J Clin Neurosci 20:1156-1158
13. Dasilva V, Breuil V, Chevallier P, Euller-Ziegler L (2010) Relapse of severe sarcoidosis with an uncommon peritoneal location after TNFalpha blockade. Efficacy of rituximab, report of a single case. Joint Bone Spine 77:82-83
14. Lower EE, Baughman RP, Kaufman AH (2012) Rituximab for refractory granulomatous eye disease. Clin Ophthalmol 6:1613-1618
15. Belkhou A, Younsi R, El Bouchti I, El Hassani S (2008) Rituximab as a treatment alternative in sarcoidosis. Joint Bone Spine 75:511-512
16. Sweiss NJ, Lower EE, Mirsaeidi M, Dudek S, Garcia JG, Perkins D et al (2014) Rituximab in the treatment of refractory pulmonary sarcoidosis. Eur Respir J 43:1525-1528
17. Gottenberg JE, Guillevin L, Lambotte O, Combe B, Allanore Y, Cantagrel A et al (2005) Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases. Ann Rheum Dis 64:913-920